American Well EBITDA Margin 2019-2025 | AMWL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for American Well (AMWL) over the last 10 years. The current EBITDA margin for American Well as of September 30, 2025 is .
| American Well EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $0.27B | $-0.09B | -32.45% |
| 2025-06-30 | $0.27B | $-0.11B | -38.89% |
| 2025-03-31 | $0.26B | $-0.14B | -52.67% |
| 2024-12-31 | $0.26B | $-0.18B | -71.37% |
| 2024-09-30 | $0.26B | $-0.20B | -76.86% |
| 2024-06-30 | $0.26B | $-0.21B | -83.59% |
| 2024-03-31 | $0.26B | $-0.23B | -89.80% |
| 2023-12-31 | $0.26B | $-0.22B | -85.71% |
| 2023-09-30 | $0.27B | $-0.23B | -86.89% |
| 2023-06-30 | $0.27B | $-0.24B | -87.59% |
| 2023-03-31 | $0.28B | $-0.24B | -87.73% |
| 2022-12-31 | $0.28B | $-0.25B | -89.17% |
| 2022-09-30 | $0.27B | $-0.23B | -84.50% |
| 2022-06-30 | $0.26B | $-0.22B | -81.44% |
| 2022-03-31 | $0.26B | $-0.19B | -72.20% |
| 2021-12-31 | $0.25B | $-0.16B | -63.24% |
| 2021-09-30 | $0.24B | $-0.17B | -69.17% |
| 2021-06-30 | $0.24B | $-0.18B | -73.44% |
| 2021-03-31 | $0.25B | $-0.23B | -91.20% |
| 2020-12-31 | $0.25B | $-0.22B | -87.40% |
| 2020-06-30 | $0.16B | $-0.13B | -84.81% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.081B | $0.254B |
| American Well Corp provides telehealth platform principally in the United States and globally. American Well Corp is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.032B | 42.83 |
| Tempus AI (TEM) | United States | $12.162B | 0.00 |
| Doximity (DOCS) | United States | $7.681B | 31.63 |
| Hims & Hers Health (HIMS) | United States | $6.948B | 56.52 |
| IRhythm Holdings (IRTC) | United States | $5.309B | 0.00 |
| Hinge Health (HNGE) | United States | $3.288B | 0.00 |
| Privia Health (PRVA) | United States | $2.947B | 184.31 |
| 10x Genomics (TXG) | United States | $2.935B | 0.00 |
| Heartflow (HTFL) | United States | $2.853B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.348B | 38.85 |
| Omnicell (OMCL) | United States | $2.303B | 47.08 |
| Azenta (AZTA) | United States | $1.886B | 77.38 |
| Clover Health Investments (CLOV) | United States | $1.385B | 0.00 |
| Enovis (ENOV) | United States | $1.347B | 7.07 |
| Schrodinger (SDGR) | United States | $1.277B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.187B | 0.00 |
| Phreesia (PHR) | United States | $0.953B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.871B | 0.00 |
| Talkspace (TALK) | United States | $0.658B | 132.33 |
| Standard BioTools (LAB) | United States | $0.619B | 0.00 |
| Claritev (CTEV) | United States | $0.497B | 0.00 |
| Evolent Health (EVH) | United States | $0.429B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.373B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.326B | 0.00 |
| TruBridge (TBRG) | United States | $0.311B | 14.31 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| CapsoVision (CV) | United States | $0.293B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.263B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.196B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.167B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.130B | 7.12 |
| Outset Medical (OM) | United States | $0.098B | 0.00 |
| Pulmonx (LUNG) | United States | $0.079B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.071B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.060B | 0.00 |
| 111 (YI) | China | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.035B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.019B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.011B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |